Browse by all authors Browse By Author Name - Morey,+Adrienne

Browse Results (9 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Bilous, Michael, Morey, Adrienne, Armes, Jane, Cummings, Margaret and Francis, Glenn (2006) Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology, 38 2: 120-124. doi:10.1080/00313020600561518 198   32 Cited 32 times in Scopus32 0
Chou, Angela, Waddell, Nicola, Cowley, Mark J., Gill, Anthony J., Chang, David K., Patch, Ann-Marie, Nones, Katia, Wu, Jianmin, Pinese, Mark, Johns, Amber L., Miller, David K., Kassahn, Karin S., Nagrial, Adnan M., Wasan, Harpreet, Goldstein, David, Toon, Christopher W., Chin, Venessa, Chantrill, Lorraine, Humphris, Jeremy, Mead, R. Scott, Rooman, Ilse, Samra, Jaswinder S., Pajic, Marina, Musgrove, Elizabeth A., Pearson, John V., Morey, Adrienne L., Grimmond, Sean M. and Biankin, Andrew V. (2013) Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Medicine, 5 8: 78.1-78.10. doi:10.1186/gm482 30   8 Cited 6 times in Scopus6 81
Farshid, Gelareh, Armes, Jane E., Bell, Richard, Cummings, Margaret, Fox, Stephen, Francis, Glenn, Haswell, Martin, Morey, Adrienne, McCue, Glenda, Raymond, Wendy, Robbins, Peter and Bilous, Michael (2010) Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: A model for the introduction of new biomarkers into clinical practice. Diagnostic Molecular Pathology, 19 4: 187-193. doi:10.1097/PDM.0b013e3181e1cc9d 6   5 Cited 5 times in Scopus5 0
Fox, Stephen B., Kumarasinghe, Marian Priyanthi, Armes, Jane E., Bilous, Michael, Cummings, Margaret C., Farshid, Gelareh, Fitzpatrick, Nicole, Francis, Glenn D., McCloud, Philip I., Raymond, Wendy and Morey, Adrienne (2012) Gastric HER2 testing study (GaTHER): An evaluation of gastric/ gastroesophageal junction cancer testing accuracy in Australia. American Journal of Surgical Pathology, 36 4: 577-582. doi:10.1097/PAS.0b013e318244adbb 67   16 Cited 17 times in Scopus17 1
Mallon, Patrick W. G., Unemori, Patrick, Sedwell, Rebecca, Morey, Adrienne, Rafferty, Martina, Williams, Kenneth, Chisholm, Donald, Samaras, Katherine, Emery, Sean, Kelleher, Anthony, Cooper, David A. and Carr, Andrew (2005) In vivo, nucleoside reverse‐transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. The Journal of Infectious Diseases, 191 10: 1686-1696. doi:10.1086/429697 57   Cited 126 times in Scopus126 0
Cummings, Margaret C., Simpson, Peter T., Reid, Lynne E., Jayanthan, Janani, Skerman, Joanna, Song, Sarah, McCart Reed, Amy E., Kutasovic, Jamie R., Morey, Adrienne L., Marquart, Louise, O'Rourke, Peter and Lakhani, Sunil R. (2014) Metastatic progression of breast cancer: Insights from 50 years of autopsies. Journal of Pathology, 232 1: 23-31. doi:10.1002/path.4288 57   6 Cited 8 times in Scopus8 6
Cooper, Wendy, Fox, Stephen, O'Toole, Sandra, Morey, Adrienne, Frances, Glenn, Pavlakis, Nick, O'Byrne, Kenneth, Dettrick, Andrew, Leong, Trishe, Rathi, Vivek, Spagnolo, Dominic, Hemmings, Chris, Singh, Mahendra, Moffat, David, Tsao, Ming-Sound, Wilner, Keith, Buller, Richard, Pitman Lowenthal, Susan, Arifeen, Shams, Binko, Justin and Alam, Mahmood (2014) National Working Group Meeting on ALK diagnostics in lung cancer. Asia-Pacific Journal of Clinical Oncology, 10 Supp. 2: 11-17. doi:10.1111/ajco.12190 34   1 Cited 1 times in Scopus1 0
Webster, Lucy R., Lee, Shu-Fen, Ringland, Clare, Morey, Adrienne L., Hanby, Andrew M., Morgan, Graeme, Byth, Karen, Mote, Patricia A., Provan, Pamela J., Ellis, Ian O., Green, Andrew R., Lamoury, Gillian, Ravdin, Peter, Clarke, Christine L., Ward, Robyn L., Balleine, Rosemary L. and Hawkins, Nicholas J. (2008) Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification. Clinical Cancer Research, 14 20: 6625-6633. doi:10.1158/1078-0432.CCR-08-0701 9   8 Cited 10 times in Scopus10 0
Webster, Lucy R., Provan, Pamela J., Graham, Dinny J., Byth, Karen, Walker, Robert L., Davis, Sean, Salisbury, Elizabeth L., Morey, Adrienne L., Ward, Robyn L., Hawkins, Nicholas J., Clarke, Christine L., Meltzer, Paul S. and Balleine, Rosemary L. (2013) Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. Pathology, 45 7: 629-636. doi:10.1097/PAT.0000000000000004 12   0 Cited 0 times in Scopus0 1